You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 4,983,527


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,983,527
Title: Oocyte test for detection of tumor promoting compounds
Abstract:A unique, quick, inexpensive and highly accurate assay for detecting the presence of tumor promoters based on a measurable set of changes in amphibian oocytes in the presence of a tumor promoter. A secondary assay based on the protein released by the oocytes is employed to confirm the initial assay and quantify the potency of the tumor promoter present.
Inventor(s): Capco; David G. (Tempe, AZ), Bement; William M. (Tempe, AZ)
Assignee: Arizona Board of Regents (Tempe, AZ)
Application Number:07/357,704
Patent Claims:1. A test for detecting the presence of tumor promoting activity in an unknown substance disposed in a preselected medium, said test comprising the steps of: admixing said unknown substance with a preselected medium to create a medium mixture; depositing said medium mixture on a Petri dish; depositing a controlled number of pretreated amphibian oocytes into said medium mixture on said Petri dish to form an Oocyte-containing medium mixture; incubating said Oocyty-containing medium mixture; measuring the surface contraction of the areas of the animal hemisphere of said oocytes occupied by a dark-colored pigment after said incubation; and comparing said contraction of said dark-colored pigment areas to that obtained by incubating an Oocyte without contact with said unknown substance to determine the percentage of said contraction of said dark-colored pigment area wherein an increase in pigment and an imbalance between the hemispheres is an indication of the presence of a tumor promoting activity.

2. A test according to claim 1 in which said amphibian is frog.

3. A test according to claim 2 in which said frog oocyte is selected from the group consisting of Xenopus laevis, Xenopus borealis and Rana pipiens.

4. A test according to claim 1 in which said measuring of surface contraction of said oocytes in said oocyte-containing medium mixture is done after about 10 to about 30 minutes of said incubation.

5. A test according to claim 3 in which said oocytes are obtained by first excising ovaries from an anesthetized female Xenopus laevis and thereafter treating said oocytes to remove follicle cells therefrom.

6. A test according to claim 5 in which said femal Xenopus laevis is anesthetized by hypothermia.

7. A test according to claim 5 in which said excised oocytes are treated with collagenase to remove follicle cells therefrom.

8. A test according to claim 5 in which said follicle cell-free oocytes are isolated, washed, and incubated for about 4-6 hours in 1.times.O-R2.

9. A test according to claim 8 in which said incubated, follicle cell-free oocytes are transferred to a Petri dish containing fresh O-R2 medium containing said unknown substance.

10. A test according to claim 1 in which said medium consists of a bath of distilled water into which the following reagents are added to provide the following concentrations:

11. A test according to claim 9 comprising inspecting the incubated oocytes to determine that each is rupture-free; transferring a portion of the medium solution containing rupture-free oocytes and unknown substance to a cuvette; placing the cuvette into a spectrophotometer; and measuring the absorbance of the medium portion at 280 nanometers.

12. A test according to claim 11 comprising concurrently preparing a plurality of cuvettes, each containing a like number of rupture-free oocytes, medium and a different concentration of said unknown substance, measuring the absorbance of each cuvette at 280 nanometers, and plotting the absorbance of each cuvette against the concentration of the unknown substance to provide a quantitative evaluation of the tumor promoting potency of said unknown substance versus the concentration thereof.

13. A test according to claim 5 comprising treating said excised oocytes with calcium-free medium to remove the follicle cells therefrom.

14. A method for confirming the presence of tumor promoting activity in an unknown substance, comprising: removing follicle cells from rupture-free amphibian oocytes; thereafter adding said rupture-free oocytes to a preselected medium to create an Oocyte-containing medium to which said unknown substance is added to form a mixture; placing a portion of said mixture in a cuvette; placing the cuvette in a spectrophotometer; measuring the absorbance of said mixture portion at 280 nanometers; and comparing the absorbance of said mixture portion with the absorbance measured using a known control wherein an increase in absorbance is an indication of the presence of tumor promoting activity.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.